Enter inventor name

Stefan Matthias Blech

This inventor holds 16 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Ingelheim Pharma Kg, Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim International Pharma Gmbh & Co. Kg. Active years: 2001-2013.

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 93.8

Average Co-Inventor Count = 5.4

ph-index = 10

Forward Citations = 392(Granted Patents)

Company Filing History:

13 out of 149

Boehringer Ingelheim Pharma Kg

patents

2 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

1 out of 1

Boehringer Ingelheim International Pharma Gmbh & Co. Kg

patent

Years Active: 2001-2013

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8586608 - Quinazoline derivatives and pharmaceutical compositions containing them (2013-11-19),

2. RE43431 - Quinazoline derivatives and pharmaceutical compositions containing them (2012-05-28),

3. 7019012 - Quinazoline derivatives and pharmaceutical compositions containing them (2006-03-28),

4. 6972288 - 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases (2005-12-06),

5. 6800623 - Method of treating schizophrenia (2004-10-05),

6. 6740651 - Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases (2004-05-25),

7. 6656946 - Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases (2003-12-02),

8. 6653305 - Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them (2003-11-25),

9. 6627634 - Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them (2003-09-30),

10. 6617329 - Aminoquinazolines and their use as medicaments (2003-09-09),

11. 6525045 - Positive allosteric AMPA receptor modulators (2003-02-25),

12. 6492377 - Imidazotriazolopyrimidines with adenosine-antagonistic activity (2002-12-10),

13. 6476047 - Anellated dihydropyridines for the treatment of chronic pain (2002-11-05),

14. 6403580 - Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing them (2002-06-11),

15. 6323207 - Benzoylguanidine derivatives (2001-11-27),

Title: The Innovations of Stefan Matthias Blech

Introduction

Stefan Matthias Blech is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work primarily focuses on the development of innovative compounds that have the potential to impact medical treatments.

Latest Patents

Among his latest patents are the Quinazoline derivatives and pharmaceutical compositions containing them. These patents involve a compound of general formula I, which showcases his expertise in creating novel pharmaceutical solutions.

Career Highlights

Stefan has had a distinguished career, working with prominent companies such as Boehringer Ingelheim Pharma KG and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Stefan has collaborated with talented individuals, including Frank Himmelsbach and Elke Langkopf. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful pharmaceutical products.

Conclusion

Stefan Matthias Blech's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and pave the way for future innovations.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]